These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8598644)

  • 1. Occurrence of a mutation associated with Wolman disease in a family with cholesteryl ester storage disease.
    Maslen CL; Babcock D; Illingworth DR
    J Inherit Metab Dis; 1995; 18(5):620-3. PubMed ID: 8598644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.
    Lohse P; Maas S; Sewell AC; van Diggelen OP ; Seidel D
    J Lipid Res; 1999 Feb; 40(2):221-8. PubMed ID: 9925650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease.
    Lohse P; Maas S; Lohse P; Elleder M; Kirk JM; Besley GT; Seidel D
    J Lipid Res; 2000 Jan; 41(1):23-31. PubMed ID: 10627498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
    Anderson RA; Bryson GM; Parks JS
    Mol Genet Metab; 1999 Nov; 68(3):333-45. PubMed ID: 10562460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.
    Ries S; Büchler C; Schindler G; Aslanidis C; Ameis D; Gasche C; Jung N; Schambach A; Fehringer P; Vanier MT; Belli DC; Greten H; Schmitz G
    Hum Mutat; 1998; 12(1):44-51. PubMed ID: 9633819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease.
    Pagani F; Pariyarath R; Garcia R; Stuani C; Burlina AB; Ruotolo G; Rabusin M; Baralle FE
    J Lipid Res; 1998 Jul; 39(7):1382-8. PubMed ID: 9684740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.
    Fasano T; Pisciotta L; Bocchi L; Guardamagna O; Assandro P; Rabacchi C; Zanoni P; Filocamo M; Bertolini S; Calandra S
    Mol Genet Metab; 2012 Mar; 105(3):450-6. PubMed ID: 22227072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal acid lipase: a pivotal enzyme in the pathogenesis of cholesteryl ester storage disease and Wolman disease.
    Ameis D; Greten H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():66-7. PubMed ID: 8767467
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural bases of Wolman disease and cholesteryl ester storage disease.
    Saito S; Ohno K; Suzuki T; Sakuraba H
    Mol Genet Metab; 2012 Feb; 105(2):244-8. PubMed ID: 22138108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
    Aslanidis C; Ries S; Fehringer P; Büchler C; Klima H; Schmitz G
    Genomics; 1996 Apr; 33(1):85-93. PubMed ID: 8617513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].
    Tanaka A
    Nihon Rinsho; 1995 Dec; 53(12):3004-8. PubMed ID: 8577049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease.
    Anderson RA; Byrum RS; Coates PM; Sando GN
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2718-22. PubMed ID: 8146180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.
    Du H; Duanmu M; Witte D; Grabowski GA
    Hum Mol Genet; 1998 Sep; 7(9):1347-54. PubMed ID: 9700186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.
    Ries S; Aslanidis C; Fehringer P; Carel JC; Gendrel D; Schmitz G
    J Lipid Res; 1996 Aug; 37(8):1761-5. PubMed ID: 8864960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease.
    Hooper AJ; Tran HA; Formby MR; Burnett JR
    Clin Chim Acta; 2008 Dec; 398(1-2):152-4. PubMed ID: 18775687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency.
    Zhang B; Porto AF
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):682-5. PubMed ID: 23403440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragenic deletion as a novel type of mutation in Wolman disease.
    Lee TM; Welsh M; Benhamed S; Chung WK
    Mol Genet Metab; 2011 Dec; 104(4):703-5. PubMed ID: 21963785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD).
    Muntoni S; Wiebusch H; Funke H; Ros E; Seedorf U; Assmann G
    Hum Genet; 1995 May; 95(5):491-4. PubMed ID: 7759067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
    Tylki-Szymańska A; Jurecka A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):99-106. PubMed ID: 24798600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare cause of hepatomegaly and dyslipidemia: lysosomal acid lipase deficiency.
    Gürbüz BB; Güney İ; Bulut FD; Dilek O
    Turk J Pediatr; 2020; 62(5):831-835. PubMed ID: 33108087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.